GlobalData predicts the average prices of dual chamber pacemakers in both India and China are expected to reduce at an average CAGR of -3.42% from 2022 to 2025.
The new center will focus on supporting the clinical trials clients who are developing cell and gene therapies
Aster DM Healthcare and Faruk Medical City will jointly provide training and academic support to medical and paramedical staff
The use of procalcitonin testing for sepsis management is highest in the US
GMP-compliant documentation of all manufacturing steps for cell and gene therapies
The service includes full fertility care benefits, including egg and embryo freezing options to employees
Expanded capacity in Nansha, China will support mid-scale manufacturing to ensure a smooth transition between early-phase and large-scale commercial production
New Lexington, Massachusetts facility to provide customer education and collaboration opportunities
Results showed a statistically significant and clinically meaningful improvement in investigator-assessed progression-free survival
Evaluating Investigational Sitravatinib in combination with Nivolumab for patients with non-squamous non-small cell lung cancer
Subscribe To Our Newsletter & Stay Updated
